Sharp John P
Transaction: 03/31/2026
OTHER
Change
0
Price
Not reported
Filing
04/28/2026
Type
OTHER
Skye Bioscience, Inc.
SKYE • Biotechnology
$1.86
▲ +0.08 (+4.49%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$73.81M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 3.3Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 11, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.86
Change4.49%
Shares Out39.68M
Market Cap$73.81M
Enterprise Value$56.76M
52W Range0.57 - 5.75
Beta2.87
P/E-1.29
P/B8.19
P/FCF-1.74
EV/EBITDA-1.00
EV/FCF-1.34
Price$1.86
Change4.49%
Shares Out39.68M
Market Cap$73.81M
Enterprise Value$56.76M
52W Range0.57 - 5.75
Beta2.87
P/E-1.29
P/B8.19
P/FCF-1.74
EV/EBITDA-1.00
EV/FCF-1.34
Earnings Yield-77.68%
FCF Yield-57.49%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio3.30
Quick Ratio3.30
Revenue 5Y-100.00%
Target$12.00
Target Upside545.16%
Target Median$15.00
Target Range2.00 - 21.00
Volume193.90K
Avg Volume200.76K
EPS Surprise-0.03
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
91/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 3.3Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
100/100
Bullish
Bullish
5
Hold
0
Bearish
0
Price Target
2026-06-24
Low
$2.00
Mean
$12.00
Median
$15.00
High
$21.00
Insider Transactions
Recent executive and insider activity
DHILLON PUNIT
Transaction: 03/31/2026
SELL
Change
-21,586
Price
$3.50
Filing
04/02/2026
Type
SELL
Diep Tuan Tu
Transaction: 03/31/2026
SELL
Change
-75,000
Price
$14.56
Filing
04/02/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Sharp John P | OTHER | 0 | Not reported | 03/31/2026 | 04/28/2026 |
| DHILLON PUNIT | SELL | -21,586 | $3.50 | 03/31/2026 | 04/02/2026 |
| Diep Tuan Tu | SELL | -75,000 | $14.56 | 03/31/2026 | 04/02/2026 |
| Schwab Andrew J. | BUY | +75,000 | $0.61 | 03/31/2026 | 04/02/2026 |
| Grayson Paul A. | BUY | +75,000 | $0.61 | 03/31/2026 | 04/02/2026 |
| Charych Deborah H. | BUY | +75,000 | $0.61 | 03/31/2026 | 04/02/2026 |
| Jenkins Annalisa | BUY | +75,000 | $0.61 | 03/31/2026 | 04/02/2026 |
| Twitty Christopher | SELL | -12,000 | $4.25 | 03/31/2026 | 04/02/2026 |
| Smith Karen L. | BUY | +75,000 | $0.61 | 03/31/2026 | 04/02/2026 |
| Diep Tuan Tu | OTHER | +9,194 | $3.50 | 03/04/2024 | 04/02/2026 |
| Diep Tuan Tu | OTHER | 0 | Not reported | 03/04/2024 | 04/02/2026 |
| DHILLON PUNIT | BUY | +280,000 | $0.82 | 02/06/2026 | 02/09/2026 |
| Arora Puneet S. | BUY | +125,000 | $0.82 | 02/06/2026 | 02/09/2026 |
| Diep Tuan Tu | BUY | +125,000 | $0.82 | 02/06/2026 | 02/09/2026 |
| Jenkins Annalisa | BUY | +35,000 | $0.82 | 02/06/2026 | 02/09/2026 |
| Charych Deborah H. | BUY | +35,000 | $0.82 | 02/06/2026 | 02/09/2026 |
| Twitty Christopher | BUY | +150,000 | $0.82 | 02/06/2026 | 02/09/2026 |
| ARSENAULT KAITLYN | BUY | +125,000 | $0.82 | 02/06/2026 | 02/09/2026 |
| Smith Karen L. | BUY | +35,000 | $0.82 | 02/06/2026 | 02/09/2026 |
| Grayson Paul A. | BUY | +35,000 | $0.82 | 02/06/2026 | 02/09/2026 |